Skip to content
GLP-1 Savers
Menu
Ranked #7 · Watch ListEditorial review

Ro review

A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.

Est. first month

Not disclosed

Get this deal Editorial review — no commercial relationship.
Pricing to watch. Won't show a compounded price until you're in the funnel — you can't compare the deal up front.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Multi-state
Brand-name
Yes

The Value Score card

Ro scored on our six published factors. See the methodology.

Lowest Real Price62/100
No Teaser-Rate Bait68/100
Nationwide Availability82/100
Both Molecules88/100
Easy Cancellation84/100
Reputation90/100

Why it's a deal

  • Brand-name (Wegovy/Zepbound) access and insurance support
  • Oral options
  • Polished, well-funded platform

Read the fine print

  • Does not publish compounded pricing up front — no way to compare the deal
  • Premium positioning
  • Editorial pick — no affiliate relationship

The bottom line

Best for: Patients who want brand-name access and insurance navigation more than a visible low price. A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.

Ranked #7 of 9 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

All 8 other programs we track, by Value Score.

Pricing, states and verification reflect Ro's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Ro's site. Not medical advice; see our disclosure.

← Back to all deals